Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGraphene Nanochem Regulatory News (GRPH)

  • There is currently no data for GRPH

Directors' Share Purchases

5 Jan 2009 12:09

RNS Number : 0917L
Biofutures International plc
05 January 2009
 



For Immediate Release

Biofutures International plc

('Biofutures' or the 'Company')

Notification of Dealings by Directors

5 January 2009

Biofutures International plc, the AIM listed investing company which seeks to establish, invest in, or acquire assets, partnerships, joint ventures, businesses or companies in Europe, Asia and the Middle East in the energy and utility sectors and their related infrastructures announces that it was notified of the following dealings by the directors of Biofutures ("Directors") on 5 January 2009 which were completed on the same day:-

Julie Pomeroy, Finance Director, purchased 400,000 ordinary shares of 1 penny each in the issued share capital of the Company ("Ordinary Shares"), representing approximately 0.26 per cent. of the issued share capital of the Company. The purchase was conducted at 1.25 pence per Ordinary Share. Following this purchase Julie Pomeroy is now beneficially interested in 600,000 Ordinary Shares which represents approximately 0.40 per cent. of the issued share capital of the Company.

David Long, Non-Executive Director, purchased 400,000 Ordinary Shares at 1.25 pence per Ordinary Share. Following this purchase David Long is now beneficially interested in 400,000 Ordinary Shares which represents approximately 0.26 per cent. of the issued share capital of the Company.

Patrick Howes, Non-Executive Director, purchased 240,000 Ordinary Shares at 1.25 pence per Ordinary Share. Following this purchase Patrick Howes is now beneficially interested in 240,000 Ordinary Shares which represents approximately 0.16 per cent. of the issued share capital of the Company.

For further information please contact:

Julie Pomeroy, Finance DirectorBiofutures International plc 0117 920 0092

Emily Morgan, Blomfield Corporate Finance Limited 01275 871 717

Paul Vann, Winningtons Financial PR  0117 920 0092

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLELFBKFBBBBV
Date   Source Headline
5th Dec 20062:39 pmRNSHolding(s) in Company
1st Dec 20062:48 pmRNSHolding(s) in Company
30th Nov 20069:20 amRNSHolding(s) in Company
29th Nov 200612:07 pmRNSHolding(s) in Company
23rd Nov 20061:43 pmRNSEGM Statement
21st Nov 20067:00 amRNSChange of Registered Address
2nd Nov 200612:33 pmRNSDirector/PDMR Shareholding
1st Nov 20062:10 pmRNSDirector/PDMR Shareholding
1st Nov 200611:40 amRNSSchedule 1 - Biofutures Int
30th Oct 20067:01 amRNSAcquisition
30th Oct 20067:01 amRNSRestoration - Biofutures Intl
22nd Sep 20067:00 amRNSMaiden Interim Results
25th Aug 20063:00 pmRNSAppt. of Finance Director
28th Jul 20062:43 pmRNSConditional Agreement
19th Jun 20069:56 amRNSHolding(s) in Company
1st Jun 200611:45 amRNSSuspension - Biofutures Intl
1st Jun 200611:45 amRNSre Press Speculation
24th May 20063:08 pmRNSHolding(s) in Company
24th May 20067:01 amRNSHolding(s) in Company
17th May 20062:45 pmRNSHolding(s) in Company
17th May 200610:19 amRNSHolding(s) in Company
15th May 200611:38 amRNSHolding(s) in Company
15th May 200610:56 amRNSHolding(s) in Company
11th May 200612:10 pmRNSHolding(s) in Company
5th May 20061:39 pmRNSDirector shareholding
5th May 200611:10 amRNSHolding(s) in Company
5th May 20069:00 amRNSPlacing & Admission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.